PIEDMONT INVESTMENT ADVISORS INC - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 38 filers reported holding CUE BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PIEDMONT INVESTMENT ADVISORS INC ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q2 2018$4,0003070.00%
Other shareholders
CUE BIOPHARMA INC shareholders Q3 2018
NameSharesValueWeighting ↓
Bleichroeder LP 755,028$1,736,5640.43%
Monaco Asset Management SAM 359,739$827,4000.24%
Slate Path Capital LP 2,402,455$5,525,6470.15%
SANDERS MORRIS HARRIS LLC 346,212$713,4260.15%
ADVISORY RESEARCH INC 257,225$591,6180.08%
Robertson Stephens Wealth Management, LLC 478,500$1,100,5500.07%
Annandale Capital, LLC 65,000$1500.04%
Good Life Advisors, LLC 112,000$257,6000.03%
CARLSON CAPITAL L P 135,000$310,5000.02%
CORNERCAP INVESTMENT COUNSEL INC 57,888$133,1420.02%
View complete list of CUE BIOPHARMA INC shareholders